“Accessibility of Medical Products for Rare Diseases” July 2023 In July we received an invitation from Doctor Eva Hilberg from Sheffield University, to participate in a […]

June 24 – 28 2023                                    Rallybio presented the important results of their FNAIT Program ‘RLYB212’ at the ‘’International Society of Thrombosis and Haemostasis Congress – […]

On April 13th at #leidenuniversity Thijs W De Vos will present his #doctorate #dissertation which provides a solid base for questioning justification for a screening program […]

  6 March 2023 Latest news on the development of a prophylactic treatment for FNAIT. NEW HAVEN, Conn.–(BUSINESS WIRE)–Mar. 6, 2023– Rallybio Corporation (Nasdaq: RLYB) today […]

Rallybio Announces Positive Preliminary Results for RLYB212, an anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia     September 28, 2022 — […]

‘He’s never alone’ Dad has his head tattooed to honour his son’s brain surgery.     Carlos Marquez, from North Bergen, New Jersey, USA wanted to […]